A Prospective Phase I/II Trial of Bortezomib-Based Graft-Versus-Host-Disease Prophylaxis in HLA-Mismatched Unrelated Donor Reduced-Intensity Conditioning Hematopoietic Stem Cell Transplantation: Encouraging Safety, Efficacy, and Survival

Saved in:

Bibliographic Details
Published in	Biology of blood and marrow transplantation Vol. 17; no. 2; pp. S165 - S166
Main Authors	Koreth, J, Stevenson, K.E, Kim, H.T, Bindra, B, McDonough, S, Ho, V.T, Cutler, C.S, Armand, P, Soiffer, R.J, Antin, J.H, Ritz, J, Alyea, E.P
Format	Journal Article
Language	English
Published	Elsevier Inc 2011
Subjects	Hematology, Oncology and Palliative Medicine
Online Access	Get full text

Loading…

More Information
ISSN:	1083-8791 1523-6536
DOI:	10.1016/j.bbmt.2010.12.044